Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Luigi Meroni

Showing results (31-40 of 315) with videos related to

Pageof 32
Sort By:
Autoimmunity Reviews|July 10, 2003
Endothelium as a target for anti-phospholipid antibodies and for therapeutical interventionPier Luigi Meroni, Elena Raschi, Cinzia Testoni
The Israel Medical Association Journal : IMAJ|September 12, 2019
Are Anti-Phospholipid Syndrome and Systemic Lupus Erythematosus Two Different Diseases? A 10-Year Late RemakePier Luigi Meroni, Elias Toubi, Yehuda Shoenfeld
Clinical and Experimental Rheumatology|January 6, 2018
Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugsPier Luigi Meroni, Daniela Zavaglia, Corrado Girmenia
Journal of Hand and Microsurgery|December 4, 2012
Power Doppler sonography and clinical monitoring for hyaluronic Acid treatment of rhizarthrosis: a pilot studyFrancesca Ingegnoli, Amedeo Soldi, Pier Luigi Meroni
Clinical Reviews in Allergy & Immunology|July 12, 2013
Less travelled roads in clinical immunology and allergy: drug reactions and the environmental influenceCarlo Selmi, Chiara Crotti, Pier Luigi Meroni
Current Opinion in Immunology|August 6, 2025
Can we cure antiphospholipid syndrome?Pier Luigi Meroni, Enrico Capobianco, Francesco Tedesco
Current Rheumatology Reports|January 7, 2014
New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodiesCecilia Beatrice Chighizola, Maria Gerosa, Pier Luigi Meroni
Autoimmunity Reviews|August 31, 2014
Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an "anchor" drug?Ennio Giulio Favalli, Martina Biggioggero, Pier Luigi Meroni
Autoimmunity Reviews|February 8, 2011
Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literatureFrancesca Ingegnoli, Ennio Giulio Favalli, Pier Luigi Meroni
Journal of Immunology Research|June 16, 2015
Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future ApproachesCecilia Beatrice Chighizola, Tania Ubiali, Pier Luigi Meroni
Pageof 32

Showing results (31-40 of 315) with videos related to

Sort By:
Pageof 32
Autoimmunity Reviews|July 10, 2003
Endothelium as a target for anti-phospholipid antibodies and for therapeutical interventionPier Luigi Meroni, Elena Raschi, Cinzia Testoni
The Israel Medical Association Journal : IMAJ|September 12, 2019
Are Anti-Phospholipid Syndrome and Systemic Lupus Erythematosus Two Different Diseases? A 10-Year Late RemakePier Luigi Meroni, Elias Toubi, Yehuda Shoenfeld
Clinical and Experimental Rheumatology|January 6, 2018
Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugsPier Luigi Meroni, Daniela Zavaglia, Corrado Girmenia
Journal of Hand and Microsurgery|December 4, 2012
Power Doppler sonography and clinical monitoring for hyaluronic Acid treatment of rhizarthrosis: a pilot studyFrancesca Ingegnoli, Amedeo Soldi, Pier Luigi Meroni
Clinical Reviews in Allergy & Immunology|July 12, 2013
Less travelled roads in clinical immunology and allergy: drug reactions and the environmental influenceCarlo Selmi, Chiara Crotti, Pier Luigi Meroni
Current Opinion in Immunology|August 6, 2025
Can we cure antiphospholipid syndrome?Pier Luigi Meroni, Enrico Capobianco, Francesco Tedesco
Current Rheumatology Reports|January 7, 2014
New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodiesCecilia Beatrice Chighizola, Maria Gerosa, Pier Luigi Meroni
Autoimmunity Reviews|August 31, 2014
Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an "anchor" drug?Ennio Giulio Favalli, Martina Biggioggero, Pier Luigi Meroni
Autoimmunity Reviews|February 8, 2011
Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literatureFrancesca Ingegnoli, Ennio Giulio Favalli, Pier Luigi Meroni
Journal of Immunology Research|June 16, 2015
Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future ApproachesCecilia Beatrice Chighizola, Tania Ubiali, Pier Luigi Meroni
Pageof 32